The cytoplasmic domains of integrins provide an important link between the ligand binding sequences in the extracellular domain and cytoplasmic components responsible for transducing signals to intracellular pathways. For activatable integrins such as alphaIIb/beta3, the cytoplasmic domains also provide a link for inside-out signals from cytoplasmic pathways to the extracellular ligand binding sequences. Despite this increased recognition of integrins as signal mediating receptors, the precise nature of these signals, the identification of those that are generated directly be integrins and those that are secondarily generated by integrins, and the relationship between these signals remain uncertain. The overall aim of this project is to identify cytoplasmic domain sequences which interact with and mediate integrin-associated signals and to use this structural information to gain a better understanding of the nature of the signals. Using site-directed mutagenesis and peptide approaches, minimal sequences in the beta 3 cytoplasmic domain which interact with alpha-actinin, talin, vinculin, and other components of integrin-associated focal adhesions will be mapped. Cytoplasmic domain sequences which interact with focal adhesion kinase (pp125/FAK) and paxillin and the role that these interactions have in focal adhesion formation and integrin activation will also be determined. The potential role of phosphorylation of tyrosine residues in the cytoplasmic tail of beta 3 and the role that phosphorylation plays in signal mediation will be examined. Finally, sequences required for the interaction and responses of integrins to components of the MAP kinase cascade and the regulation of integrin activation by H-ras and R-ras will be identified.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL045100-10
Application #
6604765
Study Section
Project Start
2002-07-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
10
Fiscal Year
2002
Total Cost
$110,268
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Wittchen, Erika S; Aghajanian, Amir; Burridge, Keith (2011) Isoform-specific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions. Small GTPases 2:65-76
Demorest, Zachary L; MacDuff, Donna A; Brown, William L et al. (2010) The interaction between AID and CIB1 is nonessential for antibody gene diversification by gene conversion or class switch recombination. PLoS One 5:e11660
Casiraghi, Monica; Tatreau, Jason R; Abano, John B et al. (2009) In vitro modeling of nonhypoxic cold ischemia-reperfusion simulating lung transplantation. J Thorac Cardiovasc Surg 138:760-7
Monaghan-Benson, Elizabeth; Burridge, Keith (2009) The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 284:25602-11
Zanotti, Giorgio; Casiraghi, Monica; Abano, John B et al. (2009) Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema. Am J Physiol Lung Cell Mol Physiol 297:L52-63
Wittchen, Erika S (2009) Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front Biosci (Landmark Ed) 14:2522-45
Sallee, Jennifer L; Burridge, Keith (2009) Density-enhanced phosphatase 1 regulates phosphorylation of tight junction proteins and enhances barrier function of epithelial cells. J Biol Chem 284:14997-5006
Wang, Z; Holly, S P; Larson, M K et al. (2009) Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activation. J Thromb Haemost 7:693-700
Aghajanian, Amir; Wittchen, Erika S; Campbell, Sharon L et al. (2009) Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS One 4:e8045
Liu, Jun; DeNofrio, Jan; Yuan, Weiping et al. (2008) Genetic manipulation of megakaryocytes to study platelet function. Curr Top Dev Biol 80:311-35

Showing the most recent 10 out of 140 publications